Puma Biotechnology Inc expected to post earnings of 8  cents a share - Earnings Preview

Puma Biotechnology

01/11/2023 02:44

* Puma Biotechnology Inc  PBYI.OQ   PBYI.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The Los Angeles California-based  company is expected to
report 
a 1.5% increase in revenue to $57.95 million from $57.1 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Puma Biotechnology
Inc is
for earnings of 8 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5​, above​ its last closing price
of $2.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  0.01        0.01       0.05      Beat    566.7
 Mar. 31 2023  -0.07       -0.07      0.03      Beat    142.9
 Dec. 31 2022  0.05        0.05       -0.12     Missed  -340​
 Sep. 30 2022  -0.06       -0.05      -0.01     Beat    81.8
 ​​Jun.        0.01        0.01       0.21      Beat    1,958.
 30 2022                                                8
 Mar. 31 2022  -0.16       -0.17      -0.08     Beat    51.8​
 Dec. 31 2021  -0.08       -0.09      0.10      Beat    214.2
 Sep. 30 2021  -0.32       -0.31      -0.90     Missed  -188.8
 This summary was machine generated November 1 at 02:44 GMT.  All
figures in US dollars  unless otherwise stated